Today and tomorrow, 28th and 29th June, pharmaphorum is on site at DTx Europe in London’s Bloomsbury area, bringing you live blogging updates from the event produced by GreyGreen, a life sc
As markets become increasingly competitive, pharmaceutical companies must find new ways to differentiate their offerings from others in a therapeutic space.
Bavarian Nordic is preparing to file for regulatory approval of a vaccine against chikungunya virus after its CHIKV VLP candidate showed protective efficacy in a second ph
To improve trial recruitment, engagement, and retention, and to increase the likelihood that trials reflect what matters most to patients, regulatory authorities increasingly point to metho